Is fluoroquinolone use controversial.

Authors

Joseph M Blondeau, Glenn S Tillotson

Published in

Expert review of anti-infective therapy. Sep 25, 2026. Epub Sep 25, 2026.

Abstract

Fluoroquinolones have been in clinical use for more than 40 years and have benefitted hundreds of millions of patients in both hospital and community settings.
Black box or prominent safety warnings from regulating agencies about rare but serious adverse events has mandated a rethinking about when and where to use these antimicrobial agents. Additionally, the critical role of some fluoroquinolones for treatment of Mycobacteria tuberculosis (TB) infection raises concerns about their use for mild community acquired infections. Regardless, fluoroquinolones remain entrenched in a broad range of infectious diseases treatment guidelines, including tuberculosis, and are integral agents in antimicrobial stewardship programs.
Fluoroquinolones are essential agents for treating infectious diseases and appropriate use of these important drugs, along with all of the antimicrobial drug classes remains of paramount importance.

PMID:
42791037
Bibliographic data and abstract were imported from PubMed on 26 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.